Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

With many biotechs and pharmas needing to fill impending revenue holes coming later in the decade, M&A is posed to pick up, but not until government and regulatory uncertainty settles down. Dealmaking ...

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...